Tenaya Therapeutics (TNYA)
(Delayed Data from NSDQ)
$0.67 USD
+0.01 (0.86%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.66 -0.01 (-1.33%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Tenaya Therapeutics, Inc. has a market cap of $108.09M, which represents its share price of $0.66 multiplied by its outstanding shares number of 162.98M. As a small-cap company, TNYA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TNYA 0.67 +0.01(0.86%)
Will TNYA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TNYA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TNYA
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference | ...
TNYA: Chardan Capital Maintains Buy Rating with Price Target of $9.00 | TNYA Stock News
Tenaya Therapeutics GAAP EPS of -$0.14 beats by $0.06
Tenaya Therapeutics reports Q2 EPS (14c), consensus (19c)
Tenaya Therapeutics Inc Reports Q2 2025 EPS of -$0.14, Beating Estimates; Net Loss at $23.3 Million